No effect of prophylactic treatment with metoprolol on cerebrovascular CO2 reactivity in migraineurs

Cephalalgia

Volumn 18, Issue 6, 1998, Pages 353-357

  Kastrup, A ^a   Thomas, C ^a   Hartmann, C ^a   Schabet, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cerebrovascular CO2 reactivity; Migraine; Rnetoprolol; Transcranial Doppler ultrasound

Indexed keywords

METOPROLOL;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRAIN BLOOD FLOW; CARBON DIOXIDE MEASUREMENT; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIGRAINE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MIGRAINE DISORDERS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0031903344     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1998.1806353.x     Document Type: Article

References (33)

1. Holroyd KA, Penzien DB, Cordingly GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991;31:333-40
2. Reznikoff GA, Manaker S, Rhodes CH. Localization and quantification of betaadrenergic receptors in human brain. Neurology 1986;36:1067-73
3. Edvinson L. Adrenoceptor mechanisms in migraine therapy. In: Amery WK, Van Nueten JM, Wauquier A, editors. The pharmacological basis of migraine therapy. London: Pitman Press, 1984:108-17
4. Anzola GP, Magoni M, Volta G. Abnormal cerebrovascular reactivity in headache-free migraineurs. Cerebrovasc Dis 1993; 3:105-10
5. Fiermonte G, Pierelli F, Pauri F, Cosentino FI, Soccorsi R, Giacomini P. Cerebrovascular CO, reactivity in migraine with aura and without aura. A transcranial Doppler study. Acta Neurol Scand 1995;92:166-9
6. 2 reactivity in migraine: assessment by transcranial Doppler ultrasound. J Neurol 1991;238:23-6
7. 2 reactivity in interictal migraineurs: a transcranial Doppler study. Headache [in press]
8. Reinecke M, Wallasch TM, Langoht HD. Abnormal autonomie cerebrovascular reactivity in migraine: clinical experience with a new transcranial Doppler method. Neurology 1989; 39 Suppl 1:324
9. Sakai F, Meyer S. Abnormal cerebrovascular reactivity in patients with migraine and cluster headache. Headache 1979; 19:257-66
10. Thie A, Carvajal-Lizano M, Schlichting U, Spitzer K, Kunze K. Multimodal tests of cerebrovascular reactivity in migraine: a transcranial Doppler study. J Neurol 1992;239:338-42
11. Thomas DT, Harpold GJ, Troost BT. Cerebrovascular reactivity in migraineurs as measured by transcranial Doppler. Cephalgia 1990;10:95-9
12. Silvestrini M, Cupini M, Troisi E, Matteis M, Bernardi G. Estimation of cerebrovascular reactivity in migraine without aura. Stroke 1995;26:81-3
13. Zwetsloot CP, Caekebeke JFV, Ferrari ODK. Vascular reactivity during migraine attacks. A transcranial Doppler study. Headache 1991;31:593-5
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:9-96
15. Aaslid PA, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982;57:769-74
16. Burki NK, Albert RK. Non-invasive monitoring of arterial blood gases. Chest 1983;83:666-70
17. 2 test for detection of hemodynamically critical carotid artery stenosis and occlusions. Eur Arch Psychiatr Neurol Sci 1986;236:162-8
18. Huber P, Handa J. Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of cerebral arteries. Invest Radiol 1967;2:17-32
19. 2 tensions. Neuroradiology 1976;10:257-62
20. 2 and diamox test: decreased reliability by changes of the vessel diameter? Cerebrovasc Dis 1995;5:397-402
21. Poulin MJ, Robbins PA. Indexes of flow and cross-sectional area of the middle cerebral artery using Doppler ultrasound during hypoxia and hypercapnia in humans. Stroke 1996;27:2244-50
22. Symon L. Pathological regulation in cerebral ischemia. In: Wood JH, editor. Cerebral blood flow. Physiologic and clinical aspects. New York: McGraw-Hill, 1987:423-4
23. Diener HC, Scholz E, Dichgans J, Gerber WD, Jack A, Niederberger U. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989;25:125-30
24. Schoenen J. Sympathetic hyperarousal in migraine? Evaluation by contingent negative variation and psychomotor testing. Effects of beta-blockers. In: Rose FC, editor. In: Advances in headache research. London: John Libbey, 1987:155-60
25. Jakobsen J, Schmidt JS, Waldemar G, Paulson OB. The acute effect of dilevalol on cerebral blood flow and oxygen consumption in normotensive humans. J Cardiovasc Pharmacol 1990;15:574-8
26. Meyer JS, Okomato S, Sari A, Itoh Y, Ericsson AD. Effects of beta-adrenergic blockade on cerebral autoregulation and chemical vasomotor control in patients with stroke. Stroke 1974;5:167-78
27. Olesen J, Hougaard K, Hertz M. Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man. Stroke 1978;9:344-9
28. Schroeder T, Schierbeck J, Howardy P, Knudsen L, Gefke K. Effect of labetalol on cerebral blood flow and middle cerebral arterial flow velocity in healthy volunteers. Neurol Res 1991;13:10-12
29. 2 responsiveness. Stroke 1976;7:291-5
30. Deshmukh VD, Harper AM, Rowan OJ, Jennett WB. Studies on neurogenic control of the cerebral circulation. Eur Neurol 1971/1972;6:166-74
31. Harper AM, Deshmukh VD, Rowan JD. The influence of sympathetic nervous activity on cerebral blood flow. Arch Neurol 1972;27:1-6
32. Gotoh F, Ebihara SI, Toyoda M. Role of the autonomic nervous system in autoregulation of human cerebral circulation. Eur Neurol 1971/1972;6:203-7
33. Meyer JS, Shimazu K, Fukuuchi Y. Cerebral dysregulation in central neurogenic orthostatic hypotension. Neurology 1973; 23:262-73